BSEResult4d ago · 14 Nov 2026, 05:25 pm

Submission of Unaudited Quarterly Financial Results of the Company for the quarter and half year ended 30th September, 2026

Nexus Surgical And Medicare Ltd · 538874

✦ AI SummaryResults

Nexus Surgical and Medicare Ltd has announced its unaudited quarterly financial results for the quarter and half year ended September 30, 2026. The company reported a profit before tax of Rs. 50.02 lakhs and a net profit of Rs. 37.43 lakhs. The results have been reviewed and recommended by the audit committee and approved by the Board of Directors.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Nexus Surgical And Medicare Ltd - 538874 - Results - Financial Results For 30-09-2026

Attachments (1)

📄

1d18b665-d00e-4297-ae4f-a39e393007e5.pdf

pdf

Download →
View document text
Date: 14th November, 2026 BSE Limited Corporate Relation Department, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001. Script Code – 538874 Sub.: Outcome of Board Meeting held on Saturday, 14th November, 2026 Dear Sir / Madam, We would like to inform you that the meeting of the Board of Directors of Nexus Surgical and Medicare Limited was held on Saturday, 14th November, 2026 at 03:30 p.m. at the Registered Office of the Company situated Gala No. 4, Saarthak, Building No. 1, Square Industrial Park, Tungarphata, Vasai (East), Palghar - 401 208 and transacted the following businesses: 1. The Board of Directors of the Company has approved the unaudited quarterly financial results of the Company for the quarter and half year ended 30th September, 2026. A copy of the same alongwith Limited Review Report on the said results is enclosed herewith. The meeting commenced at 03:30 p.m. and concluded at 05:15 p.m. Kindly take the same on your records. Thanking you. Yours faithfully, For Nexus Surgical and Medicare Limited Anish More DIN: 11070098 Managing Director Encl.: as above Nexus Surgical and Medicare Limited Statement of Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026 (Rs. in lakh, except equity per share data) Quarter ended on Half Year Ended on Year ended Sep 30, 2026 June 30, 2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Mar 31, 2026 Particulars (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) Income: Sales and Services 370.87 254.80 116.58 625.67 289.11 786.81 Other Income 1.70 2.79 - 4.49 - 2.82 Total Income 372.56 2 57.59 116.58 630.16 289.11 789.63 Expenses Purchase of stock-in-trade 97.53 60.29 42.87 157.82 118.34 238.43 Change in inventories of stock-in-trade (39.63) (5.28) 17.31 (44.91) 0 .13 6.37 Employee benefits expense 12.23 9.21 11.58 21.44 22.91 31.52 Depreciation and amortization expense 0.12 0.12 0.10 0.24 0.20 0.41 Other expense 279.58 165.97 21.52 445.55 103.95 414.15 Total Expenses 349.83 2 30.31 93.38 580.13 245.52 690.87 Profit/(loss) before Exceptional Item and Tax 22.74 27.28 23.21 50.02 43.58 9 8.75 Exceptional Item Income/(Loss) - - - - - - Profit/(loss) before Tax 22.74 27.28 23.21 50.02 43.58 9 8.75 Current Tax 5.72 6.87 5.84 12.59 10.97 24.82 Tax for earlier years - - - - - 0.40 Deferred Tax - - - - - (0.08) Tax expenses 5.72 6.87 5.84 12.59 10.97 2 5.14 Profit/(loss) for the period 17.01 20.42 17.37 37.43 32.61 73.61 Other comprehensive income (OCI), net of income tax Items that will not be reclassified to profit or loss - - - - - - Items that will be reclassified to profit or loss - - - - - - Total other comprehensive income, net of income tax - - - - - - Total other comprehensive income for the period 17.01 20.42 17.37 37.43 32.61 7 3.61 Paid-up Equity Share Capital (Equity shares of Rs. 10 each) 547.19 547.19 547.19 547.19 547.19 547.19 Reserve excluding revaluation reserves (367.21) Basic and Diluted Earning Per Share (not annualized) 0.31 0.37 0.32 0.68 0.60 1.35 Notes: 1 TheaboveUnauditedFinancialresulthavebeenreviewedandrecommendedbytheauditcommitteeandapprovedbytheBoardofDirectorsattheir meeting held on November 14, 2026. The Statutory Auditors of the Company have carried out a Limited Review of the aforesaid results. 2 Theaforesaidunaudited financialresultsforthequarterandhalfyearendedSeptember30,2026hasbeenpreparedinaccordancewithCompanies (IndianAccountingStandard)Rule,2015asprescribedunderSection133oftheCompaniesAct,2013 readwithrelevantrulesissuedthereunderandin terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements ) Regulations, 2015, as amended. 3 TheCompanyhasonlyoneoperatingsegmentandisgovernedbysimilarsetofriskandreturnhencedisclosurerequirementsasperIndAS108arenot applicable. 4 Previous period figures have been restated or regrouped or rearranged wherever necessary, to make them comparable. 5 The company has not received any shareholder / investors complaints during the quarter ended September 30, 2026. For and on behalf of Board of Directors of Nexus Surgical and Medicare Limited Anish More Managing Director DIN: 11070098 Vasai November 14, 2026 Reg Office : Gala No. 4, Saarthak, Building No. 1, Square Industrial Park, Tungarphata, Vasai (East), Palghar - 401 208, CIN No.: L33100MH1992PLC328367, E-Mail : nexuscomm92@gmail.com., Tel. No. +91 8433598185 , Website : www.nexusmed.co.in Nexus Surgical and Medicare Limited Note 6: Statement of Assets and Liabilities (Rs. in lakhs) As at As at Sep 30, 2026 Mar 31, 2026 Particulars (Unaudited) (Audited) ASSETS Non-current assets (a) Property, Plant and Equipment 2.55 1.99 (b) Deferred Tax Assets (Net) 0.79 0.79 Current assets (a) Inventories 81.45 36.53 (b) Financial Assets: (i) Trade receivables 100.85 132.37 (ii) Cash and cash equivalents 15.58 50.44 (iii) Loans and Advances 150.77 102.54 (iv) Other Financial Assets 4.25 4.25 (c) Other current Assets 25.70 36.13 Total Assets 381.93 365.05 EQUITY AND LIABILITIES Equity (a) Equity Share capital 547.19 547.19 (b) Other Equity ( 329.78) ( 367.21) LIABILITIES Current liabilities (a) Financial Liabilities (i) Trade payables 151.02 159.51 (b) Other current liabilities 13.50 25.56 Total Equity and Liabilities 381.93 365.05 Reg Office : Gala No. 4, Saarthak, Building No. 1, Square Industrial Park, Tungarphata, Vasai (East), Palghar - 401 208, CIN No.: L33100MH1992PLC328367, E-Mail : nexuscomm92@gmail.com., Tel. No. +91 8433598185 , Website : www.nexusmed.co.in Nexus Surgical and Medicare Limited Note 7: Statement of Cash Flow (Rs. in lakhs) Half year ended Half year ended Particulars Sep 30, 2026 Sep 30, 2025 Profit before tax 50.02 43.58 Adjustment to reconcile net profit to net cash provided by operating activities Interest Income (3.82) - Depreciation expenses 0.24 0.20 46.44 43.79 Change in assets & liabilities Trade receivables 31.52 11.79 Inventories (44.91) 0.13 Other Assets 10.43 (33.78) Trade payables (8.49) (36.16) Other financial & other liabilities (12.06) 8.75 Cash generated from operating activities 22.93 (5.50) Income Tax Paid 12.59 10.97 Net Cash generated from operating activities 10.34 (16.46) Cash flow from investing activities Interest Income 3.82 - Loans & advances (48.23) - Assets Purchase (0.80) - (45.21) - Cash flow from financing activities - - Net cash generated (34.87) (16.46) Cash & cash equivalents at the beginning of the year 50.44 33.13 Cash & cash equivalents at the end of the year 15.58 16.66 Reconciliation of cash and cash equivalents as per the cash flow statement Cash and cash equivalents as per above comprise of the following Cash and cash equivalents 15.58 16.66 Balances per statement of cash flows 15.58 16.66 Reg Office : Gala No. 4, Saarthak, Building No. 1, Square Industrial Park, Tungarphata, Vasai (East), Palghar - 401 208, CIN No.: L33100MH1992PLC328367, E-Mail : nexuscomm92@gmail.com., Tel. No. +91 8433598185 , Website : www.nexusmed.co.in CHARTERED ACCOUNTANTS CA SATYA PRAKASH NATANt CA SANGEETA PAREKH CA SURESHKUMAR YADAV CA ARCHANA JNN CA ANCI OSWAL DISA(ICAI),FAFD Limited Review Report on Unaudited Standalone Financial Results of Nexus Surgical and Medicare Limited for the Quarter and half Year Ended 301hSeptember 2026 under Regulation 33 of the SEBl (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended ., ,. r, , 7-01 .. - The Board of Directors Nexus Surgical and Medicare Limited We have reviewed the accompanying Statement of unaudited standalone financial results of Nexus Surgical and Medicare Limited (the "Company") for the quarter and half year ended September 30, 2026 (the "Statement") being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations"). . This Statement, which is the responsibility of the Company's management and approved by the Board of Directors of the Company, has been prepared in accordance with [Showing first 8,000 characters — download PDF for full document]